Endocrinology, Vol 128, 3138-3143, Copyright © 1991 by Endocrine Society

ARTICLES

Evidence for a specific role of vasopressin in sustaining pituitary- adrenocortical stress response in the rat

S Scaccianoce, LA Muscolo, G Cigliana, D Navarra, R Nicolai and L Angelucci
Institute of Pharmacology, Second Chair, Medical Faculty, University La Sapienza, Rome, Italy.

In the adult male Wistar rat a 2-fold 2-min restraint stress exposure, repeated 15 min apart, activated the adrenocortical secretion more than a single one would have. However, in rats with a pharmacological block of the endogenous CRF release, exogenous CRH (0.3 micrograms/kg iv), administered 15 min after a first similar dose, was unable to stimulate pituitary-adrenocortical activity above the level attained with the first peptide injection. On the contrary, in the same conditions exogenous arginine vasopressin (AVP) (0.3 micrograms/kg iv) administered 15 min after CRH, was able to further stimulate pituitary- adrenocortical activity. Using the same experimental procedure, oxytocin (0.3 micrograms/kg iv) was found to be totally inactive. The physiological import of these findings was investigated in the Brattleboro rat, genetically lacking in endogenous AVP, in which, unlike the control Long-Evans strain, the 2-fold stress exposure did not cause an increase in plasma corticosterone concentration greater than that of a single exposure. These results suggest that endogenous AVP is essential in sustaining adrenocortical activation in circumstances in which pituitary refractoriness towards CRH stimulation intervenes.

This article has been cited by other articles:

				S Hesketh, D S Jessop, S Hogg, and M S Harbuz Differential actions of acute and chronic citalopram on the rodent hypothalamic-pituitary-adrenal axis response to acute restraint stress J. Endocrinol., June 1, 2005; 185(3): 373 - 382. [Abstract] [Full Text] [PDF]

				G. W. Dent, M. A. Smith, and S. Levine Rapid Induction of Corticotropin-Releasing Hormone Gene Transcription in the Paraventricular Nucleus of the Developing Rat Endocrinology, May 1, 2000; 141(5): 1593 - 1598. [Abstract] [Full Text] [PDF]

				X.-M. Ma, S. L. Lightman, and G. Aguilera Vasopressin and Corticotropin-Releasing Hormone Gene Responses to Novel Stress in Rats Adapted to Repeated Restraint Endocrinology, August 1, 1999; 140(8): 3623 - 3632. [Abstract] [Full Text]

				T. Deak, K. T. Nguyen, A. L. Ehrlich, L. R. Watkins, R. L. Spencer, S. F. Maier, J. Licinio, M.-L. Wong, G. P. Chrousos, E. Webster, et al. The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress Endocrinology, January 1, 1999; 140(1): 79 - 86. [Abstract] [Full Text]

				J. Raber, R. D. O'Shea, F. E. Bloom, and I. L. Campbell Modulation of Hypothalamic-Pituitary-Adrenal Function by Transgenic Expression of Interleukin-6 in the CNS of Mice J. Neurosci., December 15, 1997; 17(24): 9473 - 9480. [Abstract] [Full Text] [PDF]

				X.-M. Ma, A. Levy, and S. L. Lightman Emergence of an Isolated Arginine Vasopressin (AVP) Response to Stress after Repeated Restraint: A Study of Both AVP and Corticotropin-Releasing Hormone Messenger Ribonucleic Acid (RNA) and Heteronuclear RNA Endocrinology, October 1, 1997; 138(10): 4351 - 4357. [Abstract] [Full Text] [PDF]

				D. Vashdi-Elberg, N. R. Staten, E. Sakal, R. E. McKinnie, J. Djiane, G. G. Krivi, and A. Gertler Selective Modification of Recombinant Bovine Placental Lactogen by Site-directed Mutagenesis at Its C Terminus J. Biol. Chem., March 8, 1996; 271(10): 5558 - 5564. [Abstract] [Full Text] [PDF]